ORIC Pharmaceuticals
Stock Forecast, Prediction & Price Target
ORIC Pharmaceuticals Financial Estimates
ORIC Pharmaceuticals Revenue Estimates
ORIC Pharmaceuticals EBITDA Estimates
ORIC Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $13.85M Low: $13.85M High: $13.85M avg. 0% | Avg: $12.38M Low: $12.38M High: $12.38M avg. -10.65% | |
Net Income
% change YoY
| $-77.67M N/A | $-91.47M -17.76% | $-100.69M -10.07% | Avg: $-137.70M Low: $-112.67M High: $-81.30M avg. -36.75% | Avg: $-151.69M Low: $-127.59M High: $-74.91M avg. -10.15% | Avg: $-121.16M Low: $-121.16M High: $-121.16M avg. 20.12% | |
EBITDA
% change YoY
| $-78.87M N/A | $-81.76M -3.67% | $-109.74M -34.22% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
EPS
% change YoY
| -$2.05 N/A | -$2.31 -12.68% | -$1.96 15.15% | Avg: -$1.93 Low: -$2.19 High: -$1.58 avg. 1.49% | Avg: -$2.04 Low: -$2.48 High: -$1.46 avg. -5.45% | Avg: -$2.36 Low: -$2.36 High: -$2.36 avg. -15.66% | |
Operating Expenses
% change YoY
| $78.87M N/A | $86.76M 10.01% | $110.78M 27.67% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
FAQ
What is ORIC Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -8.92% in 2025-2027.
We have gathered data from 7 analysts. Their low estimate is -112.67M, average is -137.70M and high is -81.30M.
What is ORIC Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -3.55% in 2025-2027.
We have gathered data from 6 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is ORIC Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -6.54% in 2025-2027.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$2.19, average is -$1.93 and high is $-1.58.
What is the best performing analyst?
In the last twelve months analysts have been covering ORIC Pharmaceuticals stock. The most successful analyst is Robert Burns.